Document is current
Any future updates will be listed below
-
Authors
Bulcha, Jote T.
Wang, Yi
Ma, Hong
Tai, Phillip W. L. https://orcid.org/0000-0001-7409-8344
Gao, Guangping
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS076991-01)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (1P01AI100263-01)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (4P01HL131471-02, UG3 HL147367-01)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- License Information
-
More Information
Article History
Received: 3 August 2020
Revised: 5 October 2020
Accepted: 23 October 2020
First Online: 8 February 2021
Competing interests
: G.G. is a scientific co-founder of Voyager Therapeutics, Adrenas Therapeutics, and Aspa Therapeutics, and holds equity in these companies. G.G. is an inventor on patents with potential royalties licensed to Voyager Therapeutics, Aspa Therapeutics, and other biopharmaceutical companies. The remaining authors declare no competing interests.
